Joan Llevadot
About
In The Last Decade
Joan Llevadot
17 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 78
- Molecular Biology 914
- Surgery 528
- Cardiology and Cardiovascular Medicine 364
- Cancer Research 363
- Oncology 230
Countries citing papers authored by Joan Llevadot
This map shows the geographic impact of Joan Llevadot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joan Llevadot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joan Llevadot more than expected).
Fields of papers citing papers by Joan Llevadot
This network shows the impact of papers produced by Joan Llevadot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joan Llevadot. The network helps show where Joan Llevadot may publish in the future.
Co-authorship network of co-authors of Joan Llevadot
This figure shows the co-authorship network connecting the top 25 collaborators of Joan Llevadot. A scholar is included among the top collaborators of Joan Llevadot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joan Llevadot. Joan Llevadot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 8 | |
| 3 | 7 | |
| 4 | 19 | |
| 5 | 246 | |
| 6 | HMG-CoA reductase inhibitor mobilizes bone marrow–derived endothelial progenitor cells breakdown → | 513 |
| 7 | 47 | |
| 8 | 70 | |
| 9 | HMG-CoA reductase inhibitor mobilizes bone marrow–derived endothelial progenitor cells breakdown → | 541 |
| 10 | 21 | |
| 11 | 19 | |
| 12 | New Thrombolytic Agents: Does Direct Angioplasty Still Have a Role? | 2 |
| 13 | 3 | |
| 14 | 16 | |
| 15 | 19 | |
| 16 | 23 | |
| 17 | 33 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.